Martine Clozel (born 27 December 1955) is a scientist, entrepreneur and co-founder of Actelion and Idorsia.[1]

Education and career

Clozel studied at the University of Nancy and the University of California in San Francisco. She also attended further training in physiology and pharmacology at McGill University.[2]

In 1997, she founded Actelion with her husband Jean-Paul Clozel.[3][4] The company was sold in 2017 to the American pharmaceutical and consumer products company Johnson & Johnson for US$30 billion.[5] Martine Clozel founded the pharmaceutical company Idorsia in 2017 and has since served as head of research. She is one of the most successful female company founders in Switzerland.[6]

Awards

References

  1. ↑ "Idorsia Pharmaceuticals Ltd: Idorsia congratulates its Chief Scientific Officer Martine Clozel who has been honored by". bloomberg.com. 13 November 2022. Retrieved 14 December 2022.
  2. ↑ "More entrepreneurship – Courageous transformations". idorsia.com. Retrieved 14 December 2022.
  3. ↑ Denise Roland (2 March 2017). "Actelion Began in a Garage—Now Its Founding Couple Has $1 Billion and a New Biotech Firm". wsj.com. Retrieved 14 December 2022.
  4. ↑ Pascal Züger (13 June 2018). "Das ist die Frau hinter dem Erfolg von Idorsia und Actelion". cash.ch. Retrieved 14 December 2022.
  5. ↑ John Miller (26 January 2017). "Medical couple and butcher's boy win big from Actelion sale". reuters.com. Retrieved 14 December 2022.
  6. ↑ Karen Merkel-Gyger (22 August 2018). ""Wir wissen genau, wo wir in fünf Jahren sein wollen"". handelszeitung.ch. Retrieved 14 December 2022.
  7. ↑ "Idorsia congratulates its Chief Scientific Officer Martine Clozel who has been honored by Initiative Switzerland with the Annual Prix Suisse Award". globenewswire.com. 13 November 2022. Retrieved 14 December 2022.
  8. ↑ https://actu.epfl.ch/news/epfl-celebrates-1043-new-master-s-graduates/
  9. ↑ Dominik Fischer (13 November 2022). "Martine Clozel geehrt – "sie verändert das Leben von Patienten weltweit"". 20min.ch. Retrieved 14 December 2022.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.